| Primary |
| Pain |
18.4% |
| Neuralgia |
16.0% |
| Hypertension |
8.5% |
| Diabetic Neuropathy |
6.9% |
| Epilepsy |
5.5% |
| Fibromyalgia |
4.5% |
| Post Herpetic Neuralgia |
4.0% |
| Back Pain |
3.9% |
| Myocardial Infarction |
3.7% |
| Prophylaxis |
3.7% |
| Depression |
3.5% |
| Product Used For Unknown Indication |
3.4% |
| Diabetes Mellitus |
3.3% |
| Asthma |
3.2% |
| Anxiety |
2.6% |
| Constipation |
2.1% |
| Neuropathy Peripheral |
1.9% |
| Trigeminal Neuralgia |
1.8% |
| Restless Legs Syndrome |
1.7% |
| Respiration Abnormal |
1.5% |
|
| Toxicity To Various Agents |
14.1% |
| Respiratory Arrest |
13.3% |
| Withdrawal Syndrome |
8.0% |
| Vomiting |
5.8% |
| Accidental Poisoning |
5.0% |
| Drug Abuse |
4.7% |
| Status Epilepticus |
4.7% |
| Completed Suicide |
4.4% |
| Myocardial Infarction |
4.4% |
| Tremor |
4.2% |
| Weight Increased |
3.9% |
| Poisoning |
3.6% |
| Cardiac Failure |
3.3% |
| Drug Ineffective |
3.3% |
| Suicide Attempt |
3.3% |
| Hyponatraemia |
3.0% |
| Somnolence |
3.0% |
| Suicidal Ideation |
2.8% |
| Death |
2.5% |
| Sudden Death |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
33.8% |
| Drug Use For Unknown Indication |
21.8% |
| Pain |
11.5% |
| Epilepsy |
4.9% |
| Hypertension |
3.8% |
| Neuralgia |
3.0% |
| Diabetic Neuropathy |
2.7% |
| Depression |
2.5% |
| Fibromyalgia |
2.3% |
| Suicide Attempt |
1.5% |
| Diabetes Mellitus |
1.5% |
| Trigeminal Neuralgia |
1.5% |
| Back Pain |
1.5% |
| Myocardial Infarction |
1.3% |
| Asthma |
1.2% |
| Obsessive-compulsive Disorder |
1.2% |
| Pain In Extremity |
1.1% |
| Sleep Disorder |
1.1% |
| Convulsion |
1.1% |
| Anxiety |
0.9% |
|
| Completed Suicide |
17.0% |
| Respiratory Arrest |
11.2% |
| Death |
8.8% |
| Toxicity To Various Agents |
8.3% |
| Vomiting |
5.9% |
| Suicide Attempt |
5.5% |
| Osteonecrosis |
4.8% |
| Somnolence |
4.6% |
| Poisoning |
4.5% |
| Cardio-respiratory Arrest |
3.8% |
| Lipoma |
3.5% |
| Drug Toxicity |
3.3% |
| Weight Increased |
3.0% |
| Withdrawal Syndrome |
3.0% |
| Tremor |
2.6% |
| Suicidal Ideation |
2.5% |
| Drug Ineffective |
2.3% |
| Intentional Drug Misuse |
1.9% |
| Myocardial Ischaemia |
1.7% |
| Status Epilepticus |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.8% |
| Drug Use For Unknown Indication |
25.7% |
| Pain |
8.3% |
| Hypertension |
4.7% |
| Rheumatoid Arthritis |
4.4% |
| Depression |
3.0% |
| Prophylaxis |
2.9% |
| Diabetes Mellitus |
1.7% |
| Neuralgia |
1.6% |
| Back Pain |
1.6% |
| Constipation |
1.6% |
| Multiple Sclerosis |
1.5% |
| Anxiety |
1.4% |
| Multiple Myeloma |
1.3% |
| Epilepsy |
1.3% |
| Fibromyalgia |
1.2% |
| Non-small Cell Lung Cancer |
1.1% |
| Hiv Infection |
1.1% |
| Insomnia |
1.0% |
| Type 2 Diabetes Mellitus |
1.0% |
|
| Vomiting |
13.2% |
| Somnolence |
9.4% |
| Renal Failure Acute |
8.4% |
| Weight Increased |
7.0% |
| Syncope |
6.8% |
| Weight Decreased |
5.3% |
| Urinary Tract Infection |
4.4% |
| Pyrexia |
4.3% |
| Sepsis |
4.3% |
| Death |
3.9% |
| Pneumonia |
3.9% |
| Nausea |
3.8% |
| Thrombocytopenia |
3.7% |
| Tremor |
3.5% |
| Pain In Extremity |
3.4% |
| Pulmonary Embolism |
3.4% |
| Drug Ineffective |
2.9% |
| Pain |
2.8% |
| Suicidal Ideation |
2.8% |
| Convulsion |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
20.5% |
| Pain |
15.5% |
| Myocardial Infarction |
10.5% |
| Neuralgia |
5.9% |
| Depression |
5.0% |
| Product Used For Unknown Indication |
5.0% |
| Schizophrenia, Catatonic Type |
4.2% |
| Back Pain |
3.8% |
| Trigeminal Neuralgia |
3.8% |
| Tumour Pain |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Insomnia |
3.3% |
| Angina Pectoris |
2.9% |
| Contraception |
2.9% |
| Ankylosing Spondylitis |
1.7% |
| Anxiety |
1.7% |
| Crohn's Disease |
1.7% |
| Psychomotor Hyperactivity |
1.7% |
| Anaesthesia |
1.3% |
| Analgesic Therapy |
1.3% |
|
| Drug Interaction |
18.5% |
| Somnolence |
13.0% |
| Antipsychotic Drug Level Increased |
7.4% |
| Anxiety |
5.6% |
| Hallucination, Visual |
5.6% |
| Myocardial Infarction |
5.6% |
| Renal Impairment |
5.6% |
| Sleep Apnoea Syndrome |
5.6% |
| Localised Oedema |
3.7% |
| Pregnancy |
3.7% |
| Sleep Disorder |
3.7% |
| Sopor |
3.7% |
| Trigeminal Neuralgia |
3.7% |
| Urticaria |
3.7% |
| Drug Effect Increased |
1.9% |
| Drug Ineffective |
1.9% |
| Epilepsy |
1.9% |
| Hypoglycaemia |
1.9% |
| Maternal Exposure During Pregnancy |
1.9% |
| Potentiating Drug Interaction |
1.9% |
|
